Corcept Therapeutics Incorporated (BIT:1CORT)

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	102.75	127.67	135.55	66.33	77.62	76.19
Short-Term Investments	239.48	255.67	232.67	365.34	145.92	364.51
Cash & Short-Term Investments	342.23	383.33	368.22	431.67	223.54	440.7
Cash Growth	-27.67%	4.10%	-14.70%	93.11%	-49.28%	59.69%
Accounts Receivable	64.57	53.98	41.12	31.06	27.63	26.2
Other Receivables	-	-	14	14	-	-
Total Trade Receivables	64.57	53.98	55.12	45.06	27.63	26.2
Inventory	20.27	16	15.97	17.03	17.95	21.16
Other Current Assets	24.04	21.88	27.56	16.42	10.32	6.7
Total Current Assets	443.11	471.6	458.64	499.25	266.46	478.5
Net Property, Plant & Equipment	7.31	8.01	0.32	1.78	1.52	4.18
Long-Term Investments	172.78	219.83	57.18	4.95	112.28	36.2
Other Long-Term Assets	170.53	137.52	97.15	66.52	30.54	36.6
Total Assets	801.72	840.55	621.52	583.43	423.76	571.73
Accounts Payable	23.53	15.38	17.4	11.98	6.91	10.55
Accrued Expenses	120.12	124.57	72.96	45.37	40.11	34.89
Current Portion of Leases	1.02	0.83	0.15	1.14	0.53	2.05
Other Current Liabilities	-	-	14	14	-	-
Total Current Liabilities	144.66	140.77	104.51	72.49	47.54	47.49
Long-Term Leases	5.59	6.11	-	-	-	0.5
Other Long-Term Liabilities	15.68	14.08	10.31	9.1	0.41	0.4
Total Long-Term Liabilities	21.27	20.19	10.31	9.1	0.41	0.9
Total Liabilities	165.93	160.96	114.81	81.59	47.95	48.39
Common Stock	0.14	0.14	0.13	0.13	0.13	0.12
Treasury Stock	-866.93	-696.17	-635.08	-456.15	-410.41	-75.8
Additional Paid-in Capital	900.86	832.11	738.52	662.34	591.35	516.14
Accumulated Other Comprehensive Income	2.29	-0.22	0.61	-0.87	-0.23	0.42
Retained Earnings	599.43	543.74	402.53	296.39	194.97	82.46
Shareholders' Equity	635.79	679.59	506.71	501.84	375.81	523.34
Total Liabilities & Equity	801.72	840.55	621.52	583.43	423.76	571.73
Total Debt	6.61	6.94	0.15	1.14	0.53	2.55
Net Cash (Debt)	335.62	376.4	368.07	430.53	223.01	438.15
Net Cash Growth	-10.83%	2.26%	-14.51%	93.05%	-49.10%	60.79%
Net Cash Per Share	2.84	3.32	3.29	3.71	1.77	3.53
Book Value	635.79	679.59	506.71	501.84	375.81	523.34
Book Value Per Share	5.37	5.99	4.53	4.33	2.98	4.21
Tangible Book Value	635.79	679.59	506.71	501.84	375.81	523.34
Tangible Book Value Per Share	5.37	5.99	4.53	4.33	2.98	4.21

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.